Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice. - Wikidata - awgldk - TriplyDB

Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice.

Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice.

http://www.wikidata.org/entity/Q33600478

about

Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.Problem or solution: The strange story of glucagon.Oxyntomodulin analogue increases energy expenditure via the glucagon receptor.Are peptide conjugates the golden therapy against obesity?Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1 Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD

P2860

Q47779219-39CACD6A-0D54-4544-BE01-A652277B9D34 Q50140641-3C950588-2501-40E5-B31A-3B00A7F4987D Q54981530-3964B827-53AD-4FA4-9C2F-A1E33EE1B37C Q55427238-DCE9BBBB-A7CC-4D9A-8607-04DACDD2FF99 Q58572799-B3FB38E2-6C3C-41B5-A58E-AE855D30697F Q58705640-0DC816E6-6C06-4E58-9482-292461E8382F Q59136513-3CA89BE7-E3EC-4F0A-BB38-D53E83141B67

P2860

Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice.

http://www.wikidata.org/entity/Q33600478

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Monomeric GLP-1/GIP/glucagon t ...... d dyslipidemia in female mice.

@ast

Monomeric GLP-1/GIP/glucagon t ...... d dyslipidemia in female mice.

@en

type

label

Monomeric GLP-1/GIP/glucagon t ...... d dyslipidemia in female mice.

@ast

Monomeric GLP-1/GIP/glucagon t ...... d dyslipidemia in female mice.

@en

prefLabel

Monomeric GLP-1/GIP/glucagon t ...... d dyslipidemia in female mice.

@ast

Monomeric GLP-1/GIP/glucagon t ...... d dyslipidemia in female mice.

@en

P1433

Q33600478-70AEE859-6A45-40EF-ABB3-A35E47801DC8

P1476

Q33600478-B089C9B1-1B24-406A-8B49-2F2B423F3DCA

P2093

Q33600478-396BC418-CEFA-4553-8B9D-8B202CF92E7F

Q33600478-3C5E6EB7-C717-48C6-AB6A-3AD3B50F92CA

Q33600478-536B2345-4725-4105-BAFF-725194A36259

Q33600478-771BB118-E6CA-4C39-BAFC-6726A4477FE5

Q33600478-A1A4953B-2542-406A-9F5C-A57CC39EE206

Q33600478-C5D7DFE1-FEAA-492A-9884-B8CE0193DCAB

Q33600478-F88DD51B-42F4-4E3A-B26E-8D8B5E86E2BD

P2860

Q33600478-11FDCC88-3FD7-4B32-B122-9E94ECD4935F

Q33600478-12F427BA-4FBA-4B7C-BE14-7EBFDC575047

Q33600478-16402254-4820-41B8-B164-40C60B016EB0

Q33600478-21D517F8-8E5C-4A0D-A933-A60D8FCF7C02

Q33600478-28D24DA3-FBC3-4CF0-A9AB-63670B974D7D

Q33600478-2A0AC28C-346D-4B25-921A-EA72E7090DCA

Q33600478-35183834-9EEE-4B29-9589-8306FBA8E847

Q33600478-4A111C79-E026-438B-AAF4-1A86BAB497E8

Q33600478-5216433F-8723-4D02-B84E-DD66A130B582

Q33600478-5578DBB0-837B-4215-84FE-563DBB474651

P304

Q33600478-961959C4-0211-4013-8818-FF59B2870D4F

P31

Q33600478-E3149414-8ECF-4CC5-BDE2-9F12C808069E

P356

Q33600478-9D986BCB-3440-40EA-9D80-FBED26E329D7

P433

Q33600478-4FF38DA8-6FAB-42DE-B9A5-7FB9A1C74335

P478

Q33600478-8CB90553-7BD1-4CA1-9CDB-73FD51443E55

P50

Q33600478-54CC7532-00B5-4C1A-A027-81D83B205F59

Q33600478-DC2CEF90-8E56-45C7-8621-52F28CA73DC8

P577

Q33600478-653379E0-A7C0-4BE2-838A-7A60A189A371

P698

Q33600478-816FB757-44C2-4CAE-AD83-0A92ECAEB488

P921

Q33600478-3FDEECFA-2B7A-45C0-BFBD-7438A3CBE09D

P932

Q33600478-CC0762CF-241A-46DA-A046-8C02AFE7B667

P356

J.MOLMET.2017.02.002

P1433

Molecular Metabolism

P1476

Monomeric GLP-1/GIP/glucagon t ...... d dyslipidemia in female mice.

@en

P2093

Brian Finan

http://www.w3.org/2001/XMLSchema#string

Frauke Neff

http://www.w3.org/2001/XMLSchema#string

Richard D DiMarchi

http://www.w3.org/2001/XMLSchema#string

Sigrid Jall

http://www.w3.org/2001/XMLSchema#string

Stephan Sachs

http://www.w3.org/2001/XMLSchema#string

Susanna M Hofmann

http://www.w3.org/2001/XMLSchema#string

Timo D Müller

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013

Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue.

Gender differences in drug responses.

The direct and indirect costs of both overweight and obesity: a systematic review.

Defective lipid delivery modulates glucose tolerance and metabolic response to diet in apolipoprotein E-deficient mice

The epidemiology of obesity

Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes

P304

440-446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLMET.2017.02.002

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Matthias Tschöp

Christoffer Clemmensen

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28462078

http://www.w3.org/2001/XMLSchema#string

P921

P932

5404097

http://www.w3.org/2001/XMLSchema#string